14岁的Daisy Fisher被诊断为罕见、无法治愈的CMT4J, 在英国治疗方案失败后正在寻求美国基因治疗。 Fourteen-year-old Daisy Fisher, diagnosed with rare, incurable CMT4J, is seeking U.S. gene therapy after UK treatment options failed.

来自南约克郡巴恩斯利的14岁的黛西费舍尔(Daisy Fisher)被诊断为罕见、无法治愈的CMT4J(CMT4J),这是一种神经疾病,导致肌肉逐渐衰弱、慢性疼痛和流动性丧失。 Fourteen-year-old Daisy Fisher from Barnsley, South Yorkshire, has been diagnosed with rare, incurable CMT4J, a neurological disorder causing progressive muscle weakness, chronic pain, and loss of mobility. 她的病情在延迟诊断前恶化, 发现她的手脚受到神经损伤。 After months of symptoms dismissed as "growing pains," her condition worsened before a delayed diagnosis revealed nerve damage affecting her hands and feet. 她的母亲Adele Fisher(Adele Fisher)正在筹集资金, 以支付在美国进行基因治疗试验的费用, 专家认为这可能会减慢或阻止疾病蔓延。 With no treatment available in the UK, her mother, Adele Fisher, is fundraising to cover costs for a gene therapy trial in the U.S., where experts believe it may slow or halt disease progression.